Researchers from the University of Central Florida recently received a $400,000 grant from the Juvenile Diabetes Research Foundation, which they will use to create a tube that resists infection and encapsulation and is inserted under the skin for the delivery of insulin via a pump.
Featured
Industry News NOVARTIS CORPORATION: Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
Latest News
Industry News CVS PHARMACY: CVS Health Expands Safe Medication Disposal Program in Ohio to Help Combat Prescription Drug Diversion and Misuse
Industry News EQUITAS HEALTH: Equitas Health, Prism Health North Texas Announce New Partnership to Increase Access to Affordable Prescription Drug
Federal Issues
AQUESTIVE THERAPEUTICS: Granted Temporary Restraining Order (TRO) Against Alvogen
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: PCMA Supports Legislation to Ensure Patients Pay Lowest Price for Prescription Drugs
- U.S. DEPARTMENT OF HOMELAND SECURITY: DHS Statement on Protecting the Nation from Foreign Terrorist Entry to the United States
- PHARMACEUTICAL CARE MANAGEMENT CARE ASSOCIATION: Federal Circuit Court Unanimously Strikes Down Arkansas Mandate Restricting PBM Tools
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Congressional Budget Office Score of Medicare Point-of-Sale Rebates Undermines Drugmakers’ Signature Issue
Industry News
- AMERICAN REGENT, INC.: Announces the Launch and Availability of Selenious Acid Injection, USP
- CARENET HEALTH: Expands through acquisition of Citra Health Solutions subsidiary
- EQUITAS HEALTH: Equitas Health, Prism Health North Texas Announce New Partnership to Increase Access to Affordable Prescription Drug
- REGENERON PHARMACEUTICALS, INC.: CHMP Recommends Approval of Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents
Innovation
BIOMATRIX SPECIALTY PHARMACY: Expands Expertise In Oncology And Rare And Ultra-Rare Diseases
- RENEO PHARMACEUTICALS: Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
- SALIC PHARMACEUTICALS: Launches National Initiatives Aimed At Improving Recognition Of IBS Symptoms, Early Diagnosis And Treatment
- SANOFI: FDA expands indication for Soliqua® 100/33
- DIAGNOSTIC SOLUTIONS LABORATORY: Revolutionizes Precision Medicine with GenomicInsight™ Genomic Health Profile Powered by Opus23 Explorer™
Regulatory
- AMERISOURCE BERGEN: US Bioservices Selected by Biocodex SAS to Exclusively Dispense DIACOMIT® (stiripentol)
- JAZZ PHARMACEUTICALS: Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
- SAREPTA THERAPEUTICS, INC.: Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
- SANOFI: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Alerts Sign-up